• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Moderate-to-vigorous physical activity is associated with reduced risk of dyslipidemia

byJayden BerdugoandSimon Pan
January 13, 2026
in Cardiology, Chronic Disease, Lifestyle
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this cohort of adults, moderate-to-vigorous physical activity (MVPA) was associated with a decreased risk of developing dyslipidemia while also promoting gut microbial diversity, while sedentary behaviour was associated with an increased risk. 

Evidence Rating Level: 1 (Excellent) 

Atherosclerotic cardiovascular disease is a leading cause of death globally, and dyslipidemia is a major modifiable risk factor. Physical activity (PA) is known to improve lipid levels and is protective for overall cardiovascular health. Although PA on its own is effective, sedentary behaviour is harmful, even if one meets exercise guidelines. Some previous studies suggest that less sedentary behaviour may improve cholesterol levels; however, few studies have investigated how moderate-to-vigorous physical activity (MVPA) and sedentary time together affect dyslipidemia risk. To address this research gap, this study aimed to investigate how MVPA and sedentary behaviour influence dyslipidemia risk. A total of 306 incident cases of dyslipidemia were diagnosed over a median time of 4 years. There was an inverse association between total physical activity (TPA) and dyslipidemia risk (per 1‐SD increase, HR, 0.88 [95% CI, 0.79–0.98], P=0.026). Participants in the highest levels of MVPA had a 29% lower risk of developing dyslipidemia compared to those with the lowest levels of MVPA (HR 0.71; 95% CI: 0.52-0.96; P=0.03). Prolonged sedentary time was linked to a 63% greater risk of developing dyslipidemia for those in the highest sedentary group compared to those in the lowest (HR 1.63; 95% CI: 1.19-2.22; P=0.002).  Compared to those with longer sedentary periods and lower PA, the risk of dyslipidemia was 30% lower in those with short sedentary periods and high PA (HR: 0.70; 95% CI: 0.50-0.98), about the same in those with short sedentary periods and low PA (HR: 0.99; 95% CI: 0.71-1.37), and 17% lower in those with longer sedentary periods but high PA (HR: 0.83; 95% CI: 0.60-1.16). In the low MVPA group, microbial ⍺-diversity decreased (P=0.024), and low and high MVPA groups had significant shifts in β-diversity (P≤0.005). In summary, this prospective cohort study found that MVPA weakens the association between sedentary time and the risk of dyslipidemia, while also influencing gut microbiota diversity in richness in this population of adults. 

Click here to read this study in Journal of the American Heart Association

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

RELATED REPORTS

Apixaban outperforms rivaroxaban in venous thromboembolism bleeding risk

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

Lifestyle factors including higher body mass index and smoking are associated with changes in left-atrial size and function

Tags: cardiologydyslipidemiagut microbiomephysical activity
Previous Post

Aficamten is superior to metoprolol in the management of obstructive hypertrophic cardiomyopathy

Next Post

Multidomain rehabilitation after myocardial infarction improves outcomes in older adults

RelatedReports

Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Cardiology

Apixaban outperforms rivaroxaban in venous thromboembolism bleeding risk

April 2, 2026
2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Endocrinology

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

March 30, 2026
Cardiology

Lifestyle factors including higher body mass index and smoking are associated with changes in left-atrial size and function

March 3, 2026
Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial
Cardiology

Sodium-glucose cotransporter 2 inhibitors may improve left ventricular diastolic function in hypertrophic cardiomyopathy

February 17, 2026
Next Post
β-blockers linked to improved survival in preserved ejection fraction heart failure

Multidomain rehabilitation after myocardial infarction improves outcomes in older adults

Medical vaccine exemptions increase after elimination of nonmedical exemptions

A hybrid chatbot may be effective at increasing pneumococcal vaccine uptake in older adults

Shared decision-making tool for antidepressants improves patient and physician satisfaction

Use of a mobile self-help application is associated with increased self-esteem and quality of life in individuals with intellectual disabilities

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Mezagitimab appears safe and potentially effective for persistent immune thrombocytopenia
  • Intensive multifaceted management may improve blood pressure control among low-income patients
  • A telemedicine intervention may be non-inferior to standard care for rotator cuff syndrome
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

The Classics in Medicine Paperback Released!

Over the past 30 years, the transition from print to digital media has contributed to an exponential increase in medical literature. In response, 2 Minute Medicine presents 160+ authoritative, physician-written summaries of the most cited landmark trials in medicine.

amazon-logo_blackGet-it-on-iBooks-badge

Click anywhere to close this announcement

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.